Skip to content

The effects of squint surgery on double vision and abnormal head posture in patients with Graves eye disease.

Outcome of strabismus surgery in patients with Graves’ Orbitopathy: A prospective multicenter study.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22894
Enrollment
40
Registered
2013-01-18
Start date
2013-01-31
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves'orbitopathy strabismus surgery Quality of life

Interventions

Strabismus surgery.

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. GO-patients, who are clinically and biochemically euthyroid for at least three months; 2. GO-patients, who show a stable orthoptic picture for at least three months: Stable means no greater than 5 prism dioptres change in primary position and no greater change in duction as 8°.

Exclusion criteria

Exclusion criteria: 1. GO-patients with suppression (inhibition of the image of the deviating eye in the visual cortex); 2. Presence of previously diagnosed and/or treated for squint not related to the thyroid; 3. Presence of vision less than 0,2 for one or both eyes.

Design outcomes

Primary

MeasureTime frame
Primary outcome measure will be the correlation between the changes in the field of BSV and QoL.

Secondary

MeasureTime frame
Secondary outcomes will be the influence on primary outcome of squint angle, ductions and cyclodeviation. Also, the influence of prior treatment (for instance orbital decompression) on field of BSV, change in proptosis and lid aperture and the number of complications will be recorded.

Contacts

Public ContactH.M. Jellema

Meibergdreef 9

h.m.jellema@amc.uva.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)